Adipokines, hepatokines and myokines: focus on their role and molecular mechanisms in adipose tissue inflammation

Y Ren, H Zhao, C Yin, X Lan, L Wu, X Du… - Frontiers in …, 2022 - frontiersin.org
Chronic low-grade inflammation in adipose tissue (AT) is a hallmark of obesity and
contributes to various metabolic disorders, such as type 2 diabetes and cardiovascular …

Pediatric obesity—Long‐term consequences and effect of weight loss

C Marcus, P Danielsson… - Journal of internal …, 2022 - Wiley Online Library
Childhood obesity is, according to the WHO, one of the most serious challenges of the 21st
century. More than 100 million children have obesity today. Already during childhood …

Panax ginseng and aging related disorders: A systematic review

B de Oliveira Zanuso, ARO Dos Santos… - Experimental …, 2022 - Elsevier
The aging process predisposes numerous homeostatic disorders, metabolic disorders,
cardiovascular diseases, neurodegenerative diseases, and cancer. Changes in diet and …

Interplay of skeletal muscle and adipose tissue: sarcopenic obesity

MJ Park, KM Choi - Metabolism, 2023 - Elsevier
Sarcopenic obesity is becoming a global health concern, owing to the rising older
population, causing cardiometabolic morbidity and mortality. Loss of muscle exceeding …

Effect of exercise training on fat loss—Energetic perspectives and the role of improved adipose tissue function and body fat distribution

KJ Kolnes, MH Petersen, T Lien-Iversen… - Frontiers in …, 2021 - frontiersin.org
In obesity, excessive abdominal fat, especially the accumulation of visceral adipose tissue
(VAT), increases the risk of metabolic disorders, such as type 2 diabetes mellitus (T2DM) …

[HTML][HTML] Sex-and gender-related differences in obesity: From pathophysiological mechanisms to clinical implications

A Koceva, R Herman, A Janez, M Rakusa… - International journal of …, 2024 - mdpi.com
Obesity, primarily characterized by excessive fat accumulation, is a multifactorial chronic
disease with an increasing global prevalence. Despite the well-documented epidemiology …

Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle …

R Sandireddy, S Sakthivel, P Gupta, J Behari… - Frontiers in cell and …, 2024 - frontiersin.org
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-
alcoholic fatty liver disease (NAFLD), is the most common liver disorder worldwide, with an …

[HTML][HTML] Glycolipid metabolic disorders, metainflammation, oxidative stress, and cardiovascular diseases: unraveling pathways

EP de Lima, RC Moretti Jr, K Torres Pomini… - Biology, 2024 - mdpi.com
Simple Summary Glycolipid metabolic disorders (GLMDs) result from imbalances in
glycolipid levels, leading to various health issues, including obesity, diabetes, liver …

Insights into pathogenesis, nutritional and drug approach in sarcopenia: a systematic review

RH Mellen, OS Girotto, EB Marques, LF Laurindo… - Biomedicines, 2023 - mdpi.com
Sarcopenia is a multifactorial condition related to the loss of muscle mass and strength due
to aging, eating habits, physical inactivity, or even caused by another disease. Affected …

Ubiquitin-specific proteases (USPs) and metabolic disorders

H Kitamura - International journal of molecular sciences, 2023 - mdpi.com
Ubiquitination and deubiquitination are reversible processes that modify the characteristics
of target proteins, including stability, intracellular localization, and enzymatic activity …